Page last updated: 2024-12-07

1,3,4-oxadiazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3,4-oxadiazole is a five-membered heterocyclic compound containing one oxygen and two nitrogen atoms. It is a versatile scaffold that has been widely explored for its potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science. The synthesis of 1,3,4-oxadiazoles typically involves the condensation reaction of a carboxylic acid or an amide with a hydrazine derivative. The resulting compounds exhibit a range of biological activities, including antibacterial, antifungal, antiviral, anticancer, and anti-inflammatory properties. Their importance stems from their ability to interact with various biological targets, such as enzymes, receptors, and nucleic acids. Research on 1,3,4-oxadiazoles is driven by their potential to develop novel and effective drugs for treating various diseases. The versatility of this heterocyclic system allows for the synthesis of a wide variety of derivatives with tailored properties, offering numerous opportunities for medicinal chemistry and drug discovery.'

1,3,4-oxadiazole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID97428
MeSH IDM0587802

Synonyms (24)

Synonym
288-99-3
nsc122449
1,4-oxadiazole
1-oxa-3,4-diazacyclopentadiene
nsc-122449
1,3,4-oxadiazole
[1,3,4]oxadiazole
nsc 122449
unii-20o2f20our
20o2f20our ,
AKOS016007437
1,3,4-oxadiazole [mi]
1,3,4 oxadiazole
oxdiazole
DTXSID10182987
c2h2n2o
mfcd00955535
F13208
CS-0197119
SB36397
1,3,4-oxadiazol
Q27253475
A937408
EN300-125515

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The constructed library shows reasonable, oral bioavailability drug properties as determine by using the Lipinski's Rule and similar parameters."( A Highly Efficient Diversification of 2-Amino/Amido-1,3,4-oxadiazole and 1,3,4-Thiadiazole Derivatives via Reagent-Based Cyclization of Thiosemicarbazide Intermediate on Solid-Phase.
Abdildinova, A; Choe, JH; Gong, YD; Yang, SJ, 2015
)
0.67
" However, oxidative degradation and low bioavailability limit their exogenous application as fungicides on crops."( Synthesis and antifungal activities of novel thiophene-based stilbene derivatives bearing an 1,3,4-oxadiazole unit.
He, D; Jian, W; Shang, J; Wen, L, 2019
)
0.73
" However, the oxadiazoles demonstrate high oral bioavailability and low in vivo clearance and are excellent tools for studying the role of HDAC6 in vitro and in vivo in rats and mice."( Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism.
Åstrand, A; Collins, M; Ek, M; Gunnarsson, A; Hughes, G; Johansson, J; Jung, B; Li, Q; Llinas, A; Mogemark, M; Novén, A; Pemberton, N; Ripa, L; Sandmark, J; Shamovsky, I; Tångefjord, S; Xiong, Y, 2023
)
1.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (261)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (1.53)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's140 (53.64)24.3611
2020's117 (44.83)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.06 (24.57)
Research Supply Index5.59 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index50.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews16 (6.02%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other250 (93.98%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]